Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to demonstrate that the modified LMB-89 treatment regimen for children
with newly diagnosed small noncleaved cell NHL, large cell NHL (B-cell), and B-cell acute
lymphoblastic leukemia can be delivered in this setting with acceptable toxicity.